Eli Lilly and Company

October 19, 2026

First Phase 1 data for sofetabart mipitecan, Lilly’s investigational FRα-targeting ADC, in platinum-sensitive ovarian cancer to be featured…

MMedication

October 15, 2026

In LUCENT-2, more than one in four (27.7%) Omvoh-treated patients with ulcerative colitis achieved comprehensive disease control, a…

MMedication

September 30, 2026

In TRIUMPH-2, participants with obesity and type 2 diabetes taking retatrutide 12 mg lost an average of 49.6…

HHealthcare

Jim Cramer Picks J&J (JNJ) Over Eli Lilly (LLY) and Pfizer (PFE) Among These Healthcare Stocks

September 10, 2026

On September 3, a caller asked whether to rotate out of artificial intelligence stocks and add to Eli…

HHealthcare

July 17, 2026

AtaiBeckley’s lead program, BPL-003, is designed to provide durable relief from treatment-resistant depression Acquisition expands Lilly’s neuroscience pipeline…

HHealthcare

July 10, 2026

In the news release, Lilly to present Alzheimer’s disease diagnostic and therapeutic research at AAIC 2026, including new…

HHealthcare

Is Eli Lilly (LLY) One of Billionaire Cliff Asness’ Best Healthcare Stock Picks ?

July 2, 2026

Eli Lilly and Company (NYSE:LLY) is one of billionaire Cliff Asness’ top 10 healthcare stock picks. On June…

HHealthcare

Is Eli Lilly and Company (LLY) Among the Best AI-Powered Healthcare Stocks to Buy According to Hedge Funds?

June 29, 2026

Eli Lilly and Company (NYSE:LLY) is among the Best Healthcare Stocks Stocks.On June 23, Reuters reported that Eli Lilly…

MMedication

Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) across all lines of therapy

June 26, 2026

The positive opinion is based on results from the Phase 3 BRUIN CLL-313 and BRUIN CLL-314 trials, previously…

HHealthcare

June 25, 2026

INDIANAPOLIS, June 24, 2026 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced the successful completion of…

MMedication

The Thriving Black Market for a Powerful Weight Loss Drug

June 18, 2026

Retatrutide, the most powerful weight-loss drug in development, is not expected to hit the U.S. market before next…

MMedication

Zepbound (tirzepatide) and Shaquille O'Neal launch national campaign after NBA legend learns the obstructive sleep apnea he has lived with for years is treatable

June 10, 2026

In the national campaign Watch This, O’Neal gets real about living with moderate obstructive sleep apnea (OSA) and the…

Lilly to showcase advances across its oncology pipeline at the 2026 European Society for Medical Oncology (ESMO) Congress

New composite outcomes data show patients treated with Lilly’s Omvoh (mirikizumab-mrkz) achieved comprehensive corticosteroid-free disease control in ulcerative colitis and corticosteroid-free deep remission in Crohn’s disease at one year

Lilly’s triple agonist, retatrutide, delivered substantial weight loss and A1C reduction, underscoring its potential promise for people with obesity and type 2 diabetes

Jim Cramer Picks J&J (JNJ) Over Eli Lilly (LLY) and Pfizer (PFE) Among These Healthcare Stocks

Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions

/C O R R E C T I O N — Eli Lilly and Company/

Is Eli Lilly (LLY) One of Billionaire Cliff Asness’ Best Healthcare Stock Picks ?

Is Eli Lilly and Company (LLY) Among the Best AI-Powered Healthcare Stocks to Buy According to Hedge Funds?

Lilly’s Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) across all lines of therapy

Lilly completes acquisition of Centessa Pharmaceuticals to advance treatments for sleep-wake disorders

The Thriving Black Market for a Powerful Weight Loss Drug

Zepbound (tirzepatide) and Shaquille O’Neal launch national campaign after NBA legend learns the obstructive sleep apnea he has lived with for years is treatable